Eris Lifesciences Ltd vs Vasundhara Rasayans Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 08, 2026

Key Highlights

The Latest Trading Price of ERIS Lifesciences Ltd is ₹ 1384 as of 08 May 15:12 . The P/E Ratio of ERIS Lifesciences Ltd changed from 23.1 on March 2021 to 54.8 on March 2025 . This represents a CAGR of 18.86% over 5 yearsThe P/E Ratio of Vasundhara Rasayans Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of ERIS Lifesciences Ltd changed from ₹ 8207 crore on March 2021 to ₹ 19287 crore on March 2025 . This represents a CAGR of 18.64% over 5 yearsThe Market Cap of Vasundhara Rasayans Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of ERIS Lifesciences Ltd for the Dec '25 is ₹ 807.59 crore as compare to the Sep '25 revenue of ₹ 795.5 crore. This represent the growth of 1.52% The revenue of Vasundhara Rasayans Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of ERIS Lifesciences Ltd for the Dec '25 is ₹ 264.51 crore as compare to the Sep '25 ebitda of ₹ 291.3 crore. This represent the decline of -9.2% The ebitda of Vasundhara Rasayans Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of ERIS Lifesciences Ltd changed from ₹ 89.55 crore to ₹ 108.83 crore over 7 quarters. This represents a CAGR of 11.79% The net profit of Vasundhara Rasayans Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of ERIS Lifesciences Ltd changed from 21.3 % on March 2021 to 129.35 % on March 2025 . This represents a CAGR of 43.44% over 5 yearsThe Dividend Payout of Vasundhara Rasayans Ltd changed from 16.22 % on March 2021 to 14.96 % on March 2025 . This represents a CAGR of -1.60% over 5 years .

About ERIS Lifesciences Ltd

Eris Lifesciences Limited was incorporated on January 25, 2007.
Subsequently, the name of the company was changed to 'Eris Lifesciences Private Limited' on February 9, 2007.
Further, the Company was converted into a Public Limited cCompany and the name was changed to 'Eris Lifesciences Limited' on February 2, 2017.
The Company has a manufacturing plant in Guwahati, Assam and is presently engaged in manufacturing and marketing of pharmaceutical products.
It has presence in high growth chronic, sub chronic and acute therapeutic areas that require high intervention of specialist and super specialist doctors. The company develops, manufactures and commercializes branded pharmaceutical products in selected therapeutic areas within chronic and acute categories of the Indian Pharmaceutical Market (IPM), such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infective.

About Vasundhara Rasayans Ltd

Vasundhara Rasayans Limited was incorporated in March, 1987.
The Company is the leading manufacturer and exporter of Antacids therapeutic category of Active Pharmaceutical Ingredients with annual capacity of about 1500 MT of powder or its equivalent products.
It started its operation in year 1990 with an Antacid API facility offering product in paste, powder and micronised grade of powder. The plant is located on National Highway between Mumbai and Goa in an Industrial Zone called Mahad which is about 170 KMS from Mumbai and about 125 KMS from the NSICT /JNPT Ports Mumbai.
In addition to the API manufacturing Vasundhara is also having an API intermediate plant to handle organic products with its state of the art specialised Friedel Craft reaction facility. The manufacturing area is maintained as per GMP standards.

FAQs for the comparison of ERIS Lifesciences Ltd and Vasundhara Rasayans Ltd

Which company has a larger market capitalization, ERIS Lifesciences Ltd or Vasundhara Rasayans Ltd?

Market cap of ERIS Lifesciences Ltd is 19,169 Cr while Market cap of Vasundhara Rasayans Ltd is 41 Cr

What are the key factors driving the stock performance of ERIS Lifesciences Ltd and Vasundhara Rasayans Ltd?

The stock performance of ERIS Lifesciences Ltd and Vasundhara Rasayans Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for ERIS Lifesciences Ltd and Vasundhara Rasayans Ltd?

As of May 8, 2026, the ERIS Lifesciences Ltd stock price is INR ₹1383.65. On the other hand, Vasundhara Rasayans Ltd stock price is INR ₹130.5.

How do dividend payouts of ERIS Lifesciences Ltd and Vasundhara Rasayans Ltd compare?

To compare the dividend payouts of ERIS Lifesciences Ltd and Vasundhara Rasayans Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.